前瞻性队列研究应用于中医证候疗效研究的关键问题及思考OA
Consideration on the key issues in applying prospective cohort studies to traditional Chinese medical syndrome effect assessment
疗效是中医药可持续发展的根本动力,辨证论治是中医药发挥疗效的前提,证候又是辨证论治与临床诊疗的核心,因此评价证候疗效是促进中医药高质量发展的重点和难点之一.前瞻性队列研究是中医药临床疗效评价的研究设计方法之一,其对于以辨证论治为主导的中医证候疗效评价具有独特优势.但在实际研究中存在诸多方法学问题,极易与随机对照试验设计相混淆.因此,文章探讨二者在研究设计中的区别,结合前瞻性队列研究在证候疗效研究中的实际应用,梳理研究过程中的关键环节并提出建议,以期为中医证候疗效研究带来更多启发.
Therapeutic efficacy serves as the fundamental driving force for the sustainable development of traditional Chinese medicine(TCM).Syndrome differentiation and treatment is the prerequisite for TCM to exert its therapeutic effects,and syndromes are the core of both syndrome differentiation and clinical diagnosis and treatment.Therefore,evaluating the therapeutic effects of syndromes is one of the key points and difficulties in promoting the high-quality development of TCM.Prospective cohort studies represent one of the research design methods for evaluating the clinical therapeutic effects of TCM,offering unique advantages for evaluating the therapeutic effects of TCM syndromes dominated by syndrome differentiation and treatment.However,there are numerous methodological issues in practical research,and it is easy to confuse this design with randomized controlled trials.Therefore,this article explores the differences between the two research designs.By combining the practical application of prospective cohort studies in syndrome therapeutic research,we sort out the key links in the research process and provide suggestions,aiming to bring more inspiration to TCM syndrome therapeutic research.
伊明洋;李伟珂;李海霞;王至婉
河南中医药大学第一附属医院呼吸科,郑州 450000||河南中医药大学第一临床医学院,郑州 450046河南中医药大学第一附属医院呼吸科,郑州 450000||河南中医药大学第一临床医学院,郑州 450046河南中医药大学第一附属医院呼吸科,郑州 450000||河南中医药大学呼吸疾病中医药防治省部共建协同创新中心,郑州 450046||河南省中医药防治呼吸病重点实验室,郑州 450046河南中医药大学第一附属医院呼吸科,郑州 450000||河南中医药大学呼吸疾病中医药防治省部共建协同创新中心,郑州 450046||河南省中医药防治呼吸病重点实验室,郑州 450046
前瞻性队列研究中医证候临床疗效关键环节
Prospective cohort studyChinese medicine syndromeCinical efficacyKey issues
《中华中医药杂志》 2026 (4)
1043-1046,4
国家自然科学基金项目(No.81973791),河南省中医药学科领军人才项目(No.豫卫中医函[2021]8号),河南中医药大学"双一流"创建工程中医学学科项目(No.HSRP-DFCTCM-2023-3-17)
评论